COMMUNIQUÉS West-GlobeNewswire

Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade
20/05/2026
Plans to File CTA for Ph. 1b, FIH Study, 30 – 40 Advanced Cancer Patients in ‘26 MELBOURNE, Australia, May 20, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a [...]
BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent
20/05/2026
BioStem Technologies Expands Global Placental Allograft Patent Portfolio Pompano Beach, FL, May 20, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies®, a leading regenerative medicine company focused on developing and [...]
JenaValve Appoints Tonya Porter as Vice President of Regulatory Affairs
20/05/2026
IRVINE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of Tonya Porter as Vice [...]
Alzheimer’s Research Sites Honor National Clinical Trials Day
20/05/2026
Free Memory Screenings Offered to Promote Importance of Brain Health WASHINGTON, May 20, 2026 (GLOBE NEWSWIRE) -- Alzheimer’s research sites across the country are honoring National Clinical Trials Day by offering free [...]
Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity
20/05/2026
Discussion highlights significant unmet need in ovarian cancer and the potential of ERNA-101 to address limitations of current therapies Segment also discusses evolving treatment landscape, immunologically “cold” tumors [...]
PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million
20/05/2026
TORONTO, May 20, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA; OTCQB: MDXXF) (“ PharmAla ” or the “ Company ”), a global leader in the research, development, and manufacturing of novel MDXX-class [...]
PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
20/05/2026
PETACH TIKVA, Israel, May 20, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment [...]
Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting
20/05/2026
31 vonoprazan-related clinical abstracts presented at Digestive Disease Week (DDW) 2026, including 28 independent analyses across GI conditions and three Phathom-sponsored clinical research abstracts Independent [...]
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provides Business Update
20/05/2026
IMVT-1402 showed clinically meaningful response rates of 72.7% ACR20, 54.5% ACR50 and 35.8% ACR70 at Week 16 in the open label period of its trial in difficult-to-treat rheumatoid arthritis (D2T RA); Immunovant will [...]
New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization
20/05/2026
Compared to patients adherent to monthly injectable buprenorphine, patients on other MOUD (adherent and non-adherent) were 3.5 to 8.1x more likely to return to opioid use. In a separate study, patients receiving monthly [...]
Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
20/05/2026
Company Generated $22.3 Million of Operating Income and Reported $552.4 Million of GAAP Net Income, Including Significant Non-Cash Warrant-Related Gains Company Held Approximately 2.15 Billion SKY Tokens at March 31, [...]
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
20/05/2026
ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief Executive [...]
Vistin Pharma ASA: Minutes from the annual general meeting 2026
20/05/2026
Oslo, Norway, 20 May 2026 Vistin Pharma ASA (OSE: VISTN), please find attached the minutes from the annual general meeting held today, on the 20 May 2026. Attachment Minutes from AGM Vistin Pharma ASA_20_May_2026
Glass House Brands to Host Investor Sesh V on Thursday, June 18, 2026
20/05/2026
Company to Hold its Fifth Annual ‘Investor Sesh’ in Appreciation of Investor Support and in Commitment to Transparency for Shareholders LONG BEACH, Calif. and TORONTO, May 20, 2026 (GLOBE NEWSWIRE) -- Glass House Brands [...]
Regional Health Properties Reports First Quarter 2026 Results
20/05/2026
Reported First Quarter Revenue of $21.2 million Generated Adjusted EBITDA from Operations of $0.5 million Continued Execution of Integrated Healthcare Platform Strategy ATLANTA, GA, May 20, 2026 (GLOBE NEWSWIRE) -- [...]
Aeroflow Urology Donates to National Diaper Bank Network and United Way to Improve National Health Equity
20/05/2026
Gifts to both organizations reflect Aeroflow Urology’s continuous commitment to community partnerships that directly support underserved families ASHEVILLE, N.C., May 20, 2026 (GLOBE NEWSWIRE) -- Aeroflow Urology , a [...]
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
20/05/2026
MELBOURNE, Australia, May 20, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq”) today announced the commencement of its first clinical trial for an antiparasitic drug candidate powered by Gelteq ® technology, marking a [...]
Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
20/05/2026
REDWOOD CITY, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Codexis, a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex oligonucleotide therapeutics, shared new advances in RNA [...]
Sustainability Leader Ashley McKeon Selected as Soil Health Institute’s President and CEO
20/05/2026
MORRISVILLE, N.C., May 20, 2026 (GLOBE NEWSWIRE) -- Ashley McKeon, a seasoned agriculture and sustainability executive, will lead the Soil Health Institute (SHI) into its next decade. McKeon, who previously led [...]

Pages